MaaT Pharma S.A.
MAAT.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | €72,539 | €111,264 | €90,246 | €80,962 |
| - Cash | €15,038 | €20,154 | €31,150 | €24,280 |
| + Debt | €14,405 | €15,958 | €17,171 | €14,075 |
| Enterprise Value | €71,906 | €107,068 | €76,267 | €70,757 |
| Revenue | €2,427 | €1,495 | €1,721 | €850 |
| % Growth | 62.3% | -13.1% | 102.5% | – |
| Gross Profit | €1,637 | -€76 | €1,184 | €256 |
| % Margin | 67.4% | -5.1% | 68.8% | 30.1% |
| EBITDA | -€14,636 | -€16,471 | -€12,639 | -€11,304 |
| % Margin | -603% | -1,101.7% | -734.4% | -1,329.9% |
| Net Income | -€15,085 | -€16,048 | -€12,856 | -€11,282 |
| % Margin | -621.5% | -1,073.4% | -747% | -1,327.3% |
| EPS Diluted | -1 | -1.15 | -1.05 | -0.97 |
| % Growth | 13% | -9.5% | -8.2% | – |
| Operating Cash Flow | -€15,373 | -€9,423 | -€12,608 | -€5,594 |
| Capital Expenditures | -€202 | -€581 | -€126 | -€614 |
| Free Cash Flow | -€15,575 | -€10,004 | -€12,734 | -€6,208 |